Skip to Content


In the US, Fulvestrant (fulvestrant systemic) is a member of the following drug classes: estrogen receptor antagonists, hormones/antineoplastics and is used to treat Breast Cancer and Breast Cancer - Metastatic.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antineoplastic agent: Antiestrogen

Chemical Names

7alpha-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17beta-diol (WHO)

7alpha-{9-[(4,4,5,5,5-Pentafluorpentyl)sulfinyl]nonyl}estra-1,3,5(10)-trien-3,17beta-diol (IUPAC)

Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7,17)- (USAN)

Foreign Names

  • Fulvestrantum (Latin)
  • Fulvestrant (German)
  • Fulvestrant (French)
  • Fulvestrant (Spanish)

Generic Names

  • Fulvestrant (OS: BAN, USAN, JAN)
  • ICI 182780 (IS: Zeneca)
  • ZD 182780 (IS)
  • ZD 9238 (IS: Zeneca)
  • Zeneca 182780 (IS)
  • ZM 182780 (IS)
  • Fulvestrant (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Fulvestrantum (PH: Ph. Eur. 8)

Brand Names

  • Faslodex
    AstraZeneca, Argentina; AstraZeneca, Austria; AstraZeneca, Australia; AstraZeneca, Belgium; AstraZeneca, Brazil; AstraZeneca, Canada; AstraZeneca, Switzerland; AstraZeneca, Chile; AstraZeneca, China; AstraZeneca, Colombia; AstraZeneca, Cyprus; AstraZeneca, Czech Republic; AstraZeneca, Germany; AstraZeneca, Denmark; AstraZeneca, Egypt; AstraZeneca, Spain; AstraZeneca, Finland; AstraZeneca, France; AstraZeneca, Georgia; AstraZeneca, Greece; AstraZeneca, Hong Kong; AstraZeneca, Croatia (Hrvatska); AstraZeneca, Hungary; AstraZeneca, Ireland; AstraZeneca, Israel; AstraZeneca, Iceland; AstraZeneca, Italy; AstraZeneca, Lebanon; AstraZeneca, Lithuania; AstraZeneca, Mexico; AstraZeneca, Malaysia; AstraZeneca, Norway; AstraZeneca, New Zealand; AstraZeneca, Peru; AstraZeneca, Philippines; AstraZeneca, Poland; AstraZeneca, Portugal; AstraZeneca, Romania; AstraZeneca, Serbia; AstraZeneca, Sweden; AstraZeneca, Slovenia; AstraZeneca, Slovakia; AstraZeneca, Thailand; AstraZeneca, Tunisia; AstraZeneca, Turkey; AstraZeneca, Taiwan; AstraZeneca, United States; AstraZeneca, South Africa; AstraZeneca Singapore, Singapore; AstraZeneca UK, United Kingdom; Emra-Med Arzneimittel, Austria; Haemato Pharm, Austria; Inopha, Austria
  • Faspic
    Zambon, Georgia
  • Fulvestrant Sandoz
    Sandoz, Switzerland; Sandoz, Netherlands


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.